Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
Xi Experience centre is aimed at familiarizing and bringing awareness about robotic-assisted surgery among the surgical fraternity in the country
The need for hot-melt extrusion (HME) polymers is expected to grow as the pharma industry moves to implement more continuous and sustainable processes.
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
India has the second-largest number of adults with diabetes globally, after China
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
The initial courses of Lap. Hernia Masterclass will encompass commonly performed hernia procedures
Subscribe To Our Newsletter & Stay Updated
